Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ariad highlights AP-23573 product development progress over past year

Feb. 18, 2004

Xenova studies selective MRP1 inhibitors for multidrug resistance in cancer

Feb. 18, 2004

Erbitux receives FDA approval

Feb. 17, 2004

Allergan patent covers antitumor agents for breast and prostate cancer therapy

Feb. 17, 2004

Indian scientists claim new anthramycin-based antitumor agents

Feb. 17, 2004

Good safety profile reported for BBR-3576 in patients with advanced solid tumors

Feb. 17, 2004

Novel antitumor agents in early development at Zentaris

Feb. 16, 2004

Third of four phase II trials initiated for PI-88

Feb. 13, 2004

Allergan plans IND filing for Peplin's topical drug for actinic keratosis

Feb. 13, 2004

Novel DNA intercalating agent for antitumor therapy described

Feb. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...